This review evaluated the efficacy and safety of antibiotic-impregnated cement for uninfected arthroplasty. The authors' concluded that use of antibiotic-impregnated cement lowered the infection rate by approximately 50 per cent in primary hip arthroplasty. The authors' conclusions reflect the evidence presented, but are unreliable due to possible publication bias, the number of included studies and unclear data analysis.
Study selection
Comparative studies of antibiotic-impregnated cement versus non-antibiotic cement with data on more than 100 or more primary hip replacements or 20 or more revision hip replacements were eligible for inclusion in the review. Outcome data on the incidence of deep infection and overall survival rate at the specified interval after surgery at specified follow up times was also required. Studies related to mechanical properties of cement, in vitro studies or studies of joints other than the hip were excluded from the review. The antibiotic used in the cement was gentamicin. Two reviewers, who were blinded to the source institution, journal and authors of each publication, performed the study selection. It was not stated how disagreements were resolved.
Assessment of study quality
Study quality was assessed using criteria based on the Agency for Healthcare Research and Quality's systems to rate the strength of scientific evidence. Two reviewers, who were blinded to the source institution, journal and authors of each publication, performed the validity assessment. It was not stated how disagreements were resolved.
Data extraction
Data were extracted in order to calculate risk ratios (RR), weighted mean and 95% confidence intervals (CI). The authors stated neither how the data were extracted for the review nor how many reviewers performed the data extraction.
Methods of synthesis
RRs were combined in a meta-analysis using a random-effects model. Heterogeneity was assessed using the Q statistic.
